英文名稱 | Etoposide | VP-16 | VP-16-213 |
---|---|
中文名稱 | 依托泊苷 |
CAS號(hào) | 33419-42-0 |
分子式 | C26H33FN4O7 |
分子量 | 532.56 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | 4°C, protect from light |
規(guī)格 | 庫(kù)存 | 目錄價(jià) | 會(huì)員專享價(jià) | 數(shù)量 |
---|---|---|---|---|
25 mg | In-stock | ¥88.00 | 登錄后可見(jiàn) | |
50 mg | In-stock | ¥146.00 | 登錄后可見(jiàn) | |
100 mg | In-stock | ¥236.00 | 登錄后可見(jiàn) | |
250 mg | In-stock | ¥368.00 | 登錄后可見(jiàn) | |
500 mg | In-stock | ¥466.00 | 登錄后可見(jiàn) |
英文名稱 | Etoposide | VP-16 | VP-16-213 |
---|---|
中文名稱 | 依托泊苷 |
CAS號(hào) | 33419-42-0 |
分子式 | C26H33FN4O7 |
分子量 | 532.56 |
外觀 | White to off-white powder |
儲(chǔ)存條件 | 4°C, protect from light |
Etoposide (formerly VP-16, VP-16213; Toposar; VePesid; Lastet; EPEG), a chemotherapeutic drug used for the treatments of various cancers, is a semisynthetic derivative of the naturally occuring podophyllotoxin which inhibits DNA synthesis via topoisomerase II inhibitory activity.
FBXW7 Confers Radiation Survival by Targeting p53 for Degradation.Cell Rep.
PMID: 31940492 DOI: 10.1016/j.celrep.2019.12.032
Etoposide-Anti-Human VEGF a new strategy against human melanoma cells expressing stem-like traits.
PMID: 27303923 PMCID: PMC5239464 DOI: 10.18632/oncotarget.9939
PMID: 27473919 DOI: 10.1016/j.tiv.2016.07.018